HEPATITIS C, CHRONIC

This study tested a new combination of two oral drugs, bemnifosbuvir and ruzasvir, in 275 adults with chronic hepatitis C. The main goal was to see if the treatment could clear the virus from the blood 12 weeks after finishing the medication, which would mean a cure. The approach…

This study tested if new, interferon-free drugs can cure hepatitis C in 150 adults who already had liver cancer treated successfully. The main goal was to see if the virus was gone 12 weeks after treatment. Researchers also watched for any signs of cancer returning.

This study tested whether irbesartan, a blood pressure medication, can slow the progression of liver scarring (fibrosis) in adults with chronic hepatitis C who cannot take or did not respond to antiviral therapy. Over two years, 166 participants took either irbesartan or a placeb…

This study tested a combination of two drugs, peginterferon alfa-2a and ribavirin, as a second-line treatment for chronic hepatitis C in 17 people with HIV who had not responded to their first hepatitis C treatment. The goal was to see if this approach could clear the hepatitis C…

This study tested whether treating hepatitis C at the same clinic where people get medication for opioid addiction works better than sending them to a separate infectious disease clinic. About 298 people with both hepatitis C and opioid dependence took part. The goal was to see i…

This study tested a 12-week course of telaprevir added to a longer course of peginterferon and ribavirin in 70 adults with both HIV and hepatitis C who had not been helped by earlier treatment. The goal was to see if this combination could clear the hepatitis C virus for good. Th…